Search

Your search keyword '"Solovyeva, Valeriya"' showing total 201 results
Start Over Author "Solovyeva, Valeriya"
201 results on '"Solovyeva, Valeriya"'

4. Stem cells, fitness, and aging

Author

Kitaeva, Kristina, primary, Kiyasov, Andrey, additional, Rizvanov, Albert, additional, Rutland, Catrin, additional, and Solovyeva, Valeriya, additional

Published
2023
Full Text
View/download PDF

5. List of contributors

Author

Abrantes, Margarida, primary, Alves, Raquel, additional, Anugula, Sharath, additional, Aran, Veronica, additional, Badimon, Lina, additional, Barreto, Jorge N., additional, Bartosz, Grzegorz, additional, Borges, Fernanda, additional, Borrás, Consuelo, additional, Botelho, Maria Filomena, additional, Bousquet, Jean, additional, Brehm, António M.D., additional, Brito, Gerly A.C., additional, Bultje, Daan, additional, Cabral, Ana Cristina, additional, Caetano, André, additional, Canhão, Helena, additional, Carreira, Isabel Marques, additional, Carriazo, Ana Maria, additional, Carvalho, Cristina, additional, Carvalho, Eugenia, additional, Castel-Branco, Margarida, additional, Chen, Yaohua, additional, Coelho-Filho, João M., additional, Constâncio, Vera, additional, Correia e Silva, António, additional, Costa, Deiziane V.S., additional, Costa, Elísio, additional, Costa, Inês, additional, Cunha-Oliveira, Teresa, additional, de Carvalho, Paulo, additional, De Luca, Vicenzo, additional, de Natale, Edoardo R., additional, Dias, Jorge, additional, Dias, Ronaldo P., additional, Duarte, Ana I., additional, Farrel, John, additional, Fernandez-Llimos, Fernando, additional, Ferreira, Lino, additional, Ferrucci, Luigi, additional, Figueiredo, Isabel Vitoria, additional, Ford, Jamie K., additional, Franceschi, Claudio, additional, Freitas, Alex A., additional, Furlan de Brito, Maja, additional, Giacomin, Karla C., additional, Girao, Henrique, additional, Gkikas, Ilias, additional, Gomes, Bárbara, additional, Gomes, Rodrigo M., additional, Gonçalves, Ana Cristina, additional, Goulden, Peter, additional, Grant, Marcus, additional, Grilo, Luís F., additional, Guldemond, Nick, additional, Henriques, Jorge, additional, Heringer, Manoela, additional, Illario, Maddalena, additional, Jerónimo, Carmen, additional, Jones, John G., additional, Jorge, Joana, additional, Kabiri, Yaschar, additional, Karkucinska-Wieckowska, Agnieszka, additional, Kelly, George, additional, Kirkland, James L., additional, Kitaeva, Kristina, additional, Kiyasov, Andrey, additional, Korolchuk, Viktor I., additional, Laranjo, Mafalda, additional, LaRocca, Thomas J., additional, Lavrador, Marta, additional, Lebiedzinska-Arciszewska, Magdalena, additional, Li, Zhiquan, additional, Liu, Yuezhong, additional, Lourenço, Alexandre, additional, Ma, Lina, additional, Malva, João O., additional, Martens, Christopher R., additional, Mas-Bargues, Cristina, additional, Matafome, Paulo, additional, Melo, Joana Barbosa, additional, Mendonça, Maria L. Lima, additional, Metaxakis, Athanasios, additional, Middleton, Lefkos T., additional, Moreira, Paula I., additional, Nascimento, Judite M., additional, Neto, Vivaldo M., additional, Oliveira, Paulo J., additional, Ori, Alessandro, additional, Oriá, Reinaldo B., additional, Ozanne, Susan E., additional, Padeiro, Miguel, additional, Padro, Teresa, additional, Palmeira, Carlos M., additional, Pan, Yiming, additional, Paredes, Simão, additional, Passos, João F., additional, Pereira, Edith, additional, Pereira, Francisco B., additional, Pereira, Susana P., additional, Pinton, Paolo, additional, Pires, Joana F., additional, Pires, Salomé, additional, Polidori, M. Cristina, additional, Politis, Marios, additional, Raimundo, Nuno, additional, Ramalho-Santos, João, additional, Rasmussen, Lene Juel, additional, Regateiro, Fernando J., additional, Reis, Dario D., additional, Ribeiro, Caio, additional, Ribeiro, Ilda Patrícia, additional, Ribeiro-Rodrigues, Teresa M., additional, Rizvanov, Albert, additional, Rocha, Teresa, additional, Röhr, Susanne, additional, Rolo, Anabela P., additional, Román-Domínguez, Aurora, additional, Romero-Ortuno, Roman, additional, Rosa, Manuel Santos, additional, Rutland, Catrin, additional, Sadowska-Bartosz, Izabela, additional, Santana, Paula, additional, Santinha, Deolinda, additional, Santos, Marcos, additional, Sarmento Ribeiro, Ana Bela, additional, Semedo, Deisa S.R.C., additional, Sequeira, João, additional, Sierra, Felipe, additional, Silva, Maria Natalina L., additional, Solana, Rafael, additional, Solovyeva, Valeriya, additional, Spínola, Hélder, additional, Tavares, Renata S., additional, Tavernarakis, Nektarios, additional, Tchkonia, Tamar, additional, Theng, Yin-Leng, additional, Traver-Salcedo, Vicente, additional, Udeh-Momoh, Chi, additional, Verma, Rakhi, additional, Victorelli, Stella, additional, Vilaça, Andreia, additional, Vilahur, Gemma, additional, Viña, José, additional, von Zglinicki, Thomas, additional, Wahl, Devin, additional, Werle, Berenice Maria, additional, Wieckowski, Mariusz R., additional, Wilson, Heather, additional, Wissler Gerdes, Erin O., additional, Wozniak, Lucyna A., additional, Zavan, Barbara, additional, Zhu, Yi, additional, and Zischka, Hans, additional

Published
2023
Full Text
View/download PDF

8. Extracellular vesicles as brain tumor biomarkers.

Author

GILAZIEVA, ZAREMA, MOLDAVSKII, DANIIL, LUZINA, EKATERINA, KADYROVA, AISYLU, SHAIMARDANOVA, ALISA, ISSA, SHAZA, RIZVANOV, ALBERT, and SOLOVYEVA, VALERIYA

Subjects
BRAIN tumors, EXTRACELLULAR vesicles, TUMOR markers, OVERALL survival, BRAIN damage
Abstract

Aggressive malignant brain tumors have a poor prognosis, and early detection can significantly improve treatment effectiveness and increase patient survival rates. Various methods are available for diagnosing brain tumors, with biopsy being one of the primary options. However, a biopsy is an invasive procedure that carries a risk of brain damage, highlighting the need for safer alternatives. One promising non-invasive method is liquid biopsy, which involves extracting extracellular vesicles (EVs) from different biological fluids. Most cell types can produce and release extracellular vesicles. EVs isolated from bodily fluids, along with the molecules they carry—such as proteins, nucleic acids, and lipids—can be used to diagnose brain tumors. This approach has the potential to replace labor-intensive and expensive diagnostic methods that can adversely affect patient health. This review discusses recent advancements in the use of EVs as biomarkers for diagnosing brain tumors. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

9. The Crisis of the Multiculturalism Policy in Sweden

Author

Matveevskaya, Anna, Solovyeva, Valeriya, Pogodin, Sergey, Ermolina, Marina, Brilly, Mitja, Advisory Editor, Davis, Richard A., Advisory Editor, Hoalst-Pullen, Nancy, Advisory Editor, Leitner, Michael, Advisory Editor, Patterson, Mark W., Advisory Editor, Veress, Márton, Advisory Editor, Bolgov, Radomir, editor, Atnashev, Vadim, editor, Gladkiy, Yury, editor, Leete, Art, editor, Tsyb, Alexey, editor, and Pogodin, Sergey, editor

Published
2021
Full Text
View/download PDF

11. Extracellular Matrix as a Target in Melanoma Therapy: From Hypothesis to Clinical Trials.

Author

Mayasin, Yuriy P., Osinnikova, Maria N., Kharisova, Chulpan B., Kitaeva, Kristina V., Filin, Ivan Y., Gorodilova, Anna V., Kutovoi, Grigorii I., Solovyeva, Valeriya V., Golubev, Anatolii I., and Rizvanov, Albert A.

Subjects
IMMUNE checkpoint inhibitors, DEVELOPMENTAL biology, EXTRACELLULAR matrix, MATRIX metalloproteinases, CANCER invasiveness
Abstract

Melanoma is a malignant, highly metastatic neoplasm showing increasing morbidity and mortality. Tumor invasion and angiogenesis are based on remodeling of the extracellular matrix (ECM). Selective inhibition of functional components of cell–ECM interaction, such as hyaluronic acid (HA), matrix metalloproteinases (MMPs), and integrins, may inhibit tumor progression and enhance the efficacy of combination treatment with immune checkpoint inhibitors (ICIs), chemotherapy, or immunotherapy. In this review, we combine the results of different approaches targeting extracellular matrix elements in melanoma in preclinical and clinical studies. The identified limitations of many approaches, including side effects, low selectivity, and toxicity, indicate the need for further studies to optimize therapy. Nevertheless, significant progress in expanding our understanding of tumor biology and the development of targeted therapies holds great promise for the early approaches developed several decades ago to inhibit metastasis through ECM targeting. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

12. Adeno-Associated Viral Vectors in the Treatment of Epilepsy.

Author

Mullagulova, Aysilu I., Timechko, Elena E., Solovyeva, Valeriya V., Yakimov, Alexey M., Ibrahim, Ahmad, Dmitrenko, Diana D., Sufianov, Albert A., Sufianova, Galina Z., and Rizvanov, Albert A.

Subjects
GENETIC vectors, EPILEPSY, GENE therapy, TRANSCRIPTION factors, ADENO-associated virus
Abstract

Epilepsy is a brain disorder characterized by a persistent predisposition to epileptic seizures. With various etiologies of epilepsy, a significant proportion of patients develop pharmacoresistance to antiepileptic drugs, which necessitates the search for new therapeutic methods, in particular, using gene therapy. This review discusses the use of adeno-associated viral (AAV) vectors in gene therapy for epilepsy, emphasizing their advantages, such as high efficiency of neuronal tissue transduction and low immunogenicity/cytotoxicity. AAV vectors provide the possibility of personalized therapy due to the diversity of serotypes and genomic constructs, which allows for increasing the specificity and effectiveness of treatment. Promising orientations include the modulation of the expression of neuropeptides, ion channels, transcription, and neurotrophic factors, as well as the use of antisense oligonucleotides to regulate seizure activity, which can reduce the severity of epileptic disorders. This review summarizes the current advances in the use of AAV vectors for the treatment of epilepsy of various etiologies, demonstrating the significant potential of AAV vectors for the development of personalized and more effective approaches to reducing seizure activity and improving patient prognosis. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

13. The Well-Forgotten Old: Platelet-Rich Plasma in Modern Anti-Aging Therapy.

Author

Gorodilova, Anna V., Kharisova, Chulpan B., Osinnikova, Maria N., Kitaeva, Kristina V., Filin, Ivan Y., Mayasin, Yuriy P., Solovyeva, Valeriya V., and Rizvanov, Albert A.

Subjects
PLATELET-rich plasma, GERONTOLOGY, VASCULAR endothelial growth factors, GROWTH factors, REGENERATIVE medicine, CHEMOKINE receptors
Abstract

Currently, approaches to personalized medicine are actively developing. For example, the use of platelet-rich plasma (PRP) is actively growing every year. As a result of activation, platelets release a wide range of growth factors, cytokines, chemokines, and angiogenic factors, after which these molecules regulate chemotaxis, inflammation, and vasomotor function and play a crucial role in restoring the integrity of damaged vascular walls, angiogenesis, and tissue regeneration. Due to these characteristics, PRP has a wide potential in regenerative medicine and gerontology. PRP products are actively used not only in esthetic medicine but also to stimulate tissue regeneration and relieve chronic inflammation. PRP therapy has a number of advantages, but the controversial results of clinical studies, a lack of standardization of the sample preparation of the material, and insufficient objective data on the evaluation of efficacy do not allow us to unambiguously look at the use of PRP for therapeutic purposes. In this review, we will examine the current clinical efficacy of PRP-based products and analyze the contribution of PRP in the therapy of diseases associated with aging. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

18. Growth Factors and Their Application in the Therapy of Hereditary Neurodegenerative Diseases.

Author

Issa, Shaza, Fayoud, Haidar, Shaimardanova, Alisa, Sufianov, Albert, Sufianova, Galina, Solovyeva, Valeriya, and Rizvanov, Albert

Subjects
HUNTINGTON disease, ALZHEIMER'S disease, PARKINSON'S disease, GROWTH factors, GENETIC disorders
Abstract

Hereditary neurodegenerative diseases (hNDDs) such as Alzheimer's, Parkinson's, Huntington's disease, and others are primarily characterized by their progressive nature, severely compromising both the cognitive and motor abilities of patients. The underlying genetic component in hNDDs contributes to disease risk, creating a complex genetic landscape. Considering the fact that growth factors play crucial roles in regulating cellular processes, such as proliferation, differentiation, and survival, they could have therapeutic potential for hNDDs, provided appropriate dosing and safe delivery approaches are ensured. This article presents a detailed overview of growth factors, and explores their therapeutic potential in treating hNDDs, emphasizing their roles in neuronal survival, growth, and synaptic plasticity. However, challenges such as proper dosing, delivery methods, and patient variability can hinder their clinical application. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

19. Contributors

Author

Allegrucci, Cinzia, primary, Argyriou, Amerikos, additional, Caron, Jérôme, additional, Cheung, Hoi-Hung, additional, Chulpanova, Daria S., additional, Csobonyeiová, M., additional, Dubart-Kupperschmitt, Anne, additional, Eiges, Rachel, additional, Ge, Jingping, additional, Guan, Kaomei, additional, Hämäläinen, Riikka H., additional, Handal, Tayma, additional, Kitaeva, Kristina V., additional, Luo, Jiesi, additional, Modi, Shalem R., additional, Mullagulova, Aysilu I., additional, Murphy, George P., additional, Newman, Katie, additional, Olofsen, Patricia A., additional, Poetsch, Mareike S., additional, Rennert, Owen M., additional, Rizvanov, Albert A., additional, Rojnuckarin, Ponlapat, additional, Shaimardanova, Alisa A., additional, Solovyeva, Valeriya V., additional, Steinberg, Martin H., additional, Touw, Ivo P., additional, Vanuytsel, Kim, additional, Wang, Tao, additional, and Weber, Anne, additional

Published
2021
Full Text
View/download PDF

25. iPSCs for modeling lysosomal storage diseases

Author

Chulpanova, Daria S., primary, Shaimardanova, Alisa A., additional, Solovyeva, Valeriya V., additional, Mullagulova, Aysilu I., additional, Kitaeva, Kristina V., additional, Allegrucci, Cinzia, additional, and Rizvanov, Albert A., additional

Published
2020
Full Text
View/download PDF

44. Gene and Cell Therapy for Epilepsy: A Mini Review

Author

Shaimardanova, Alisa A., primary, Chulpanova, Daria S., additional, Mullagulova, Aysilu I., additional, Afawi, Zaid, additional, Gamirova, Rimma G., additional, Solovyeva, Valeriya V., additional, and Rizvanov, Albert A., additional

Published
2022
Full Text
View/download PDF

49. The Role of Cancer Stem Cells and Their Extracellular Vesicles in the Modulation of the Antitumor Immunity.

Author

Chulpanova, Daria S., Rizvanov, Albert A., and Solovyeva, Valeriya V.

Subjects
EXTRACELLULAR vesicles, CELL populations, CANCER stem cells, STEM cells, DISEASE relapse, CANCER invasiveness
Abstract

Cancer stem cells (CSCs) are a population of tumor cells that share similar properties to normal stem cells. CSCs are able to promote tumor progression and recurrence due to their resistance to chemotherapy and ability to stimulate angiogenesis and differentiate into non-CSCs. Cancer stem cells can also create a significant immunosuppressive environment around themselves by suppressing the activity of effector immune cells and recruiting cells that support tumor escape from immune response. The immunosuppressive effect of CSCs can be mediated by receptors located on their surface, as well as by secreted molecules, which transfer immunosuppressive signals to the cells of tumor microenvironment. In this article, the ability of CSCs to regulate the antitumor immune response and a contribution of CSC-derived EVs into the avoidance of the immune response are discussed. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

50. Serum Cytokine Profile, Beta-Hexosaminidase A Enzymatic Activity and GM2 Ganglioside Levels in the Plasma of a Tay-Sachs Disease Patient after Cord Blood Cell Transplantation and Curcumin Administration: A Case Report

Author

Shaimardanova, Alisa A., primary, Chulpanova, Daria S., additional, Solovyeva, Valeriya V., additional, Garanina, Ekaterina E., additional, Salafutdinov, Ilnur I., additional, Laikov, Alexander Vladimirovich, additional, Kursenko, Vadim V., additional, Chakrabarti, Lisa, additional, Zakharova, Ekaterina Yu., additional, Bukina, Tatiana M., additional, Baydakova, Galina V., additional, and Rizvanov, Albert Anatolyevich, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results